Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2021 group results

Feb 14 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           9.23            8.09           9.40          4.90    
               (+14.1 pct)     (+6.6 pct)                              
  Operating       1.05           752 mln        830 mln      580 mln   
               (+39.4 pct)     (+85.6 pct)    (-20.9 pct)  (-19.1 pct) 
  Recurring       1.10           817 mln        870 mln      610 mln   
               (+34.5 pct)     (+73.7 pct)    (-20.9 pct)  (-18.9 pct) 
  Net
  Net            737 mln         674 mln        580 mln      400 mln   
               (+9.4 pct)     (+183.2 pct)    (-21.3 pct)  (-18.4 pct) 
  EPS          126.94 yen      113.70 yen     100.14 yen    69.06 yen  
  Ann Div       36.00 yen       34.00 yen      36.00 yen               
  -Q2 Div       12.00 yen       8.00 yen       16.00 yen               
  -Q4 Div       24.00 yen       26.00 yen      20.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news